Centre de Biophysique Moléculaire, CNRS, Orléans, France.
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Cell. 2023 Oct 12;186(21):4475-4495. doi: 10.1016/j.cell.2023.08.030.
ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent emergence of new technologies to study ADP-ribosylation has reshaped our understanding of the molecular mechanisms that govern the establishment, removal, and recognition of this modification, as well as its impact on cellular and organismal function. These advances have also revealed the intricate involvement of ADP-ribosylation in human physiology and pathology and the enormous potential that their manipulation holds for therapy. In this review, we present the state-of-the-art findings covering the work in structural biology, biochemistry, cell biology, and clinical aspects of ADP-ribosylation.
ADP-核糖基化是一种普遍存在的生物分子修饰方式,包括蛋白质和核酸,它调节所有生命领域的各种细胞功能。最近出现的新技术来研究 ADP-核糖基化已经改变了我们对控制这种修饰的建立、去除和识别以及其对细胞和机体功能影响的分子机制的理解。这些进展还揭示了 ADP-核糖基化在人类生理学和病理学中的复杂作用以及对其进行操纵在治疗中的巨大潜力。在这篇综述中,我们介绍了涵盖 ADP-核糖基化的结构生物学、生物化学、细胞生物学和临床方面的最新研究成果。